Skip to main content
. Author manuscript; available in PMC: 2020 Dec 29.
Published in final edited form as: Cancer Control. 2017 Jan;24(1):89–95. doi: 10.1177/107327481702400115

Fig 4. —

Fig 4. —

Log-rank test results illustrating ERBB4 expression and OS. Probability values were as follows: all 3 levels, P = .020; low vs intermediate, P = .080; low vs high, P = .004; and intermediate vs high, P = .201.

ERBB4 = erb-b2 receptor tyrosine kinase 4, OS = overall survival.